Advanced Search
Now showing items 1-10 of 14
Commentary: Evaluation of Models of Parkinson's Disease
(Frontiers Media, 2016-04)
Neurotoxins as Preclinical Models for Parkinson’s Disease
(Springer New York LLC, 2018)
Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
(American Chemical Society, 2017)
Aminochrome as new preclinical model to find new pharmacological treatment that stop the development of parkinsons disease
(Bentham Science Publishers B.V., 2016)
Commentary: Evaluation of models of Parkinson's disease
(Frontiers Media S.A., 2016)
The need of a new and more physiological preclinical model for Parkinson's disease
(Birkhauser Verlag AG, 2016)
Commentary: Gene therapy: A promising approach for neuroprotection in Parkinson’s disease?
(Frontiers Media S.A., 2017)